Bleeding may be continuous but is usually episodic.

Objective To evaluate the safety and clinical value of regional citrate anticoagulation (RCA) to continuous venovenous hemofiltration (CVVH) for patients with a high risk of bleeding.

As a continuous extracorporeal therapy, CRRT often requires continuous anticoagulation, which can increase bleeding risk.